Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

Comment: Tau vs 14-3-3 protein--adjuncts for the diagnosis of CJD.

Drachman DA.

Neurology. 2012 Aug 7;79(6):551. doi: 10.1212/WNL.0b013e3182635834. No abstract available.

PMID:
22843263
2.

A comparison of tau and 14-3-3 protein in the diagnosis of Creutzfeldt-Jakob disease.

Karch A, Zerr I.

Neurology. 2013 May 28;80(22):2081. doi: 10.1212/01.wnl.0000431029.13491.59c. No abstract available.

PMID:
23713090
3.

Diagnostic value of 14-3-3beta immunoblot and T-tau/P-tau ratio in clinically suspected Creutzfeldt-Jakob disease.

Blennow K, Johansson A, Zetterberg H.

Int J Mol Med. 2005 Dec;16(6):1147-9.

PMID:
16273298
4.

Cerebrospinal fluid biomarkers in Creutzfeldt-Jakob disease.

Van Everbroeck B, Boons J, Cras P.

Clin Neurol Neurosurg. 2005 Aug;107(5):355-60. Review.

PMID:
16023527
5.

Total tau protein in cerebrospinal fluid and diffusion-weighted MRI as an early diagnostic marker for Creutzfeldt-Jakob disease.

Satoh K, Shirabe S, Tsujino A, Eguchi H, Motomura M, Honda H, Tomita I, Satoh A, Tsujihata M, Matsuo H, Nakagawa M, Eguchi K.

Dement Geriatr Cogn Disord. 2007;24(3):207-12.

PMID:
17690553
6.

Prion disease: diagnostic value of cerebrospinal fluid markers.

Parchi P, Capellari S.

Nat Rev Neurol. 2013 Jan;9(1):10-1. doi: 10.1038/nrneurol.2012.253. No abstract available.

PMID:
23208112
7.

14-3-3 protein, total tau and phosphorylated tau in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease and neurodegenerative disease in Japan.

Satoh K, Shirabe S, Eguchi H, Tsujino A, Eguchi K, Satoh A, Tsujihata M, Niwa M, Katamine S, Kurihara S, Matsuo H.

Cell Mol Neurobiol. 2006 Feb;26(1):45-52.

PMID:
16633900
8.

[Clinical typing and diagnosis of sporadic human prion diseases (classic sproadic CJD, MM2-cortical form CJD, MM2-thalamic form CJD)].

Satoh K, Shirabe S, Eguchi K.

Nihon Rinsho. 2007 Aug;65(8):1423-32. Review. Japanese.

PMID:
17695279
9.

[New investigations in suspected Creutzfeldt-Jakob disease. Analysis of 14-3-3 protein and T-tau in cerebrospinal fluid for safer diagnosis].

Zetterberg H, Hammarin AL, Nilsson P, Andersson E, Lind B, Blennow K.

Lakartidningen. 2005 Mar 21-Apr 3;102(12-13):956-8, 960-1. Swedish.

PMID:
15887642
10.

Elevated levels of tau protein in cerebrospinal fluid of patients with probable Creutzfeldt-Jakob disease.

Wang GR, Gao C, Shi Q, Zhou W, Chen JM, Dong CF, Shi S, Wang X, Wei Y, Jiang HY, Han J, Dong XP.

Am J Med Sci. 2010 Oct;340(4):291-5. doi: 10.1097/MAJ.0b013e3181e92a1f.

PMID:
20881758
11.
12.

The role of cerebrospinal fluid proteins as early diagnostic markers for sporadic Creutzfeldt-Jakob disease.

Pennington C, Chohan G, Mackenzie J, Andrews M, Will R, Knight R, Green A.

Neurosci Lett. 2009 May 8;455(1):56-9. doi: 10.1016/j.neulet.2009.02.067.

PMID:
19429106
13.

Tau protein and 14-3-3 protein in the differential diagnosis of Creutzfeldt-Jakob disease.

Otto M, Wiltfang J, Cepek L, Neumann M, Mollenhauer B, Steinacker P, Ciesielczyk B, Schulz-Schaeffer W, Kretzschmar HA, Poser S.

Neurology. 2002 Jan 22;58(2):192-7.

PMID:
11805244
14.

The prepared tau exon-specific antibodies revealed distinct profiles of tau in CSF of the patients with Creutzfeldt-Jakob disease.

Chen C, Shi Q, Zhang BY, Wang GR, Zhou W, Gao C, Tian C, Mei GY, Han YL, Han J, Dong XP.

PLoS One. 2010 Jul 29;5(7):e11886. doi: 10.1371/journal.pone.0011886.

15.

Alternative application of Tau protein in Creutzfeldt-Jakob disease diagnosis: Improvement for weakly positive 14-3-3 protein in the laboratory.

Hyeon JW, Kim SY, Lee J, Park JS, Hwang KJ, Lee SM, An SA, Lee MK, Ju YR.

Sci Rep. 2015 Oct 28;5:15283. doi: 10.1038/srep15283.

16.

Serum tau protein as a marker for the diagnosis of Creutzfeldt-Jakob disease.

Noguchi-Shinohara M, Hamaguchi T, Nozaki I, Sakai K, Yamada M.

J Neurol. 2011 Aug;258(8):1464-8. doi: 10.1007/s00415-011-5960-x.

PMID:
21360196
17.

A prospective study of CSF markers in 250 patients with possible Creutzfeldt-Jakob disease.

Van Everbroeck B, Quoilin S, Boons J, Martin JJ, Cras P.

J Neurol Neurosurg Psychiatry. 2003 Sep;74(9):1210-4.

18.

A comparison of tau and 14-3-3 protein in the diagnosis of Creutzfeldt-Jakob disease.

Hamlin C, Puoti G, Berri S, Sting E, Harris C, Cohen M, Spear C, Bizzi A, Debanne SM, Rowland DY.

Neurology. 2012 Aug 7;79(6):547-52. doi: 10.1212/WNL.0b013e318263565f.

19.

Follow-up investigations of tau protein and S-100B levels in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease.

Cepek L, Steinacker P, Mollenhauer B, Wiese B, Ciesielczyk B, Bibl M, Wiltfang J, Zerr I, Schulz-Schaeffer W, Kretzschmar HA, Poser S, Otto M.

Dement Geriatr Cogn Disord. 2005;19(5-6):376-82.

PMID:
15802913
20.

Phosphorylated 14-3-3zeta protein in the CSF of neuroleptic-treated patients.

Zanusso G, Fiorini M, Farinazzo A, Gelati M, Benedetti MD, Ferrari S, Dalla Libera A, Capaldi S, Monaco HL, Rizzuto N, Monaco S.

Neurology. 2005 May 10;64(9):1618-20.

PMID:
15883327
Items per page

Supplemental Content

Support Center